| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ani Pharmaceuticals, Inc. (ANIP) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. ANIP is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 431.9K | $34.33M | - | |
| CEO | 411.2K | $32.69M | - | |
| CFO | 230.9K | $18.35M | - | |
| VP | 158.5K | $12.60M | - | |
| Other | 91.3K | $7.26M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 19, 2024 | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 27,232 | $65.10 | $1,772,729.07 | -1.7% | -6.3% | +3.9% | |
| Apr 17, 2024 | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 22,768 | $65.91 | $1,500,589.42 | -0.9% | -1.9% | +5.7% | |
| Apr 12, 2024 | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 250 | $67.79 | $16,947.50 | -0.4% | -3.9% | +1.9% | |
| Apr 1, 2024 | Gassert Chad60 | SVP - Corp. Dev. &Strategy | Sell | 20,000 | $67.25 | $1,345,000.00 | -7.3% | -6.5% | +0.2% | |
| Mar 13, 2024 | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 250 | $66.54 | $16,635.00 | -0.4% | -2.0% | -7.2% | |
| Mar 11, 2024 | Gassert Chad60 | SVP - Corp. Dev. &Strategy | Sell | 20,000 | $65.81 | $1,316,200.00 | -6.8% | -1.7% | -7.2% | |
| Mar 11, 2024 | Carey Stephen P.55 | SVP &CFO | Sell | 7,787 | $65.55 | $510,437.85 | -4.2% | -1.7% | -7.2% | |
| Mar 8, 2024 | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 10,000 | $67.17 | $671,700.00 | -1.2% | +2.1% | -10.1% | |
| Mar 8, 2024 | Lalwani Nikhil66 | President &CEO | Sell | 45,257 | $66.10 | $2,991,468.76 | -5.0% | +2.1% | -10.1% | |
| Mar 7, 2024 | Marken James G.47 | SVP Ops &Prod Dev | Sell | 24,338 | $66.37 | $1,615,313.06 | -16.4% | +0.4% | -9.1% |